Diffusion-weighted MRI predicts the histologic response for neoadjuvant therapy in patients with pancreatic cancer: a prospective study (DIFFERENT trial)

被引:23
作者
Okada, Ken-ichi [1 ]
Kawai, Manabu [1 ]
Hirono, Seiko [1 ]
Kojima, Fumiyoshi [2 ]
Tanioka, Kensuke [3 ]
Terada, Masaki [4 ]
Miyazawa, Motoki [1 ]
Kitahata, Yuji [1 ]
Iwahashi, Yoshifumi [2 ]
Ueno, Masaki [1 ]
Hayami, Shinya [1 ]
Murata, Shin-ichi [2 ]
Shimokawa, Toshio [3 ]
Yamaue, Hiroki [1 ]
机构
[1] Wakayama Med Univ, Dept Surg 2, Wakayama, Wakayama 6418510, Japan
[2] Wakayama Med Univ, Dept Human Pathol, Wakayama, Wakayama 6418510, Japan
[3] Wakayama Med Univ, Clin Study Support Ctr, Wakayama, Wakayama 6418510, Japan
[4] Wakayama Minami Radiol Clin, Wakayama, Wakayama 6410012, Japan
基金
日本学术振兴会;
关键词
Apparent diffusion coefficient; R0; resectability; Borderline resectable; PACLITAXEL PLUS GEMCITABINE; NAB-PACLITAXEL; PREOPERATIVE CHEMORADIATION; TUMOR RESPONSE; PHASE I/II; ADENOCARCINOMA; CHEMOTHERAPY; COEFFICIENT; CARCINOMA; SURVIVAL;
D O I
10.1007/s00423-020-01857-4
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose Pre-operative prediction of histological response to neoadjuvant therapy aids decisions regarding surgical management of borderline resectable pancreatic cancer (BRPC). We elucidate correlation between pre-/post-treatment whole-tumor apparent diffusion coefficient (ADC) value and rate of tumor cell destruction. We newly verify whether post-treatment ADC value at the site of vascular contact predicts R0 resectability of BRPC. Methods We prospectively reviewed 28 patients with BRPC who underwent diffusion-weighted magnetic resonance imaging before neoadjuvant chemotherapy and surgery. Correlation between the percentage of tumor cell destruction and various parameters was analyzed. Strong parameters were assessed for their ability to predict therapeutic histological response and R0 resectability. Results Pre-/post-treatment whole-tumor ADC value correlated with tumor cell destruction rate by all parameters (R = 0.630/0.714, P < 0.001/< 0.0001). The post-treatment cutoff value of ADC at the site of vascular contact for discriminating histological response of tumor destruction of <= 50% and tumor destruction of > 50% was determined at 1.42 x 10(-3) mm(2)/s. It predicts R0 with 88% sensitivity, 50% specificity, and 61% accuracy. For histological response, the post-treatment whole-tumor ADC cutoff value for discriminating between tumor destruction of <= 50% and tumor destruction of > 50% was determined at 1.40 x 10(-3) mm(2)/s. It predicts histological response with 100% sensitivity, 81% specificity, and 89% accuracy. It predicts R0 with 88% sensitivity, 70% specificity, and 75% accuracy. Conclusions Post-treatment whole-tumor ADC value may be a predictor of R0 resectability in patients with BRPC. Tumor cell destruction rate is indicated by the difference between pre-/post-treatment ADC values. This difference is strongly affected by the pre-treatment ADC value. The cutoff value of ADC at the site of vascular contact could not discriminate R0 resectability.
引用
收藏
页码:23 / 33
页数:11
相关论文
共 31 条
[1]   FDG-PET predicts treatment efficacy and surgical outcome of pre-operative chemoradiation therapy for resectable and borderline resectable pancreatic cancer [J].
Akita, H. ;
Takahashi, H. ;
Ohigashi, H. ;
Tomokuni, A. ;
Kobayashi, S. ;
Sugimura, K. ;
Miyoshi, N. ;
Moon, J. -H. ;
Yasui, M. ;
Omori, T. ;
Miyata, H. ;
Ohue, M. ;
Fujiwara, Y. ;
Yano, M. ;
Ishikawa, O. ;
Sakon, M. .
EJSO, 2017, 43 (06) :1061-1067
[2]   Diffusion-weighted MRI and MR- volumetry - in the evaluation of tumor response after preoperative chemoradiotherapy in patients with locally advanced rectal cancer [J].
Birlik, Bilge ;
Obuz, Funda ;
Elibol, Funda D. ;
Celik, Ahmet O. ;
Sokmen, Selman ;
Terzi, Cem ;
Sagol, Ozgul ;
Sarioglu, Sulen ;
Gorken, Ilknur ;
Oztop, Ilhan .
MAGNETIC RESONANCE IMAGING, 2015, 33 (02) :201-212
[3]   Locally Advanced Pancreatic Adenocarcinoma: Reassessment of Response with CT after Neoadjuvant Chemotherapy and Radiation Therapy [J].
Cassinotto, Christophe ;
Mouries, Amaury ;
Lafourcade, Jean-Pierre ;
Terrebonne, Eric ;
Belleannee, GeneviSve ;
Blanc, Jean-Frederic ;
Lapuyade, Bruno ;
Vendrely, Veronique ;
Laurent, Christophe ;
Chiche, Laurence ;
Wagner, Tristan ;
Sa-Cunha, Antonio ;
Gaye, Delphine ;
Trillaud, Herve ;
Laurent, Francois ;
Montaudon, Michel .
RADIOLOGY, 2014, 273 (01) :108-116
[4]   Histologic grading of the extent of residual carcinoma following neoadjuvant chemoradiation in pancreatic ductal adenocarcinoma [J].
Chatterjee, Deyali ;
Katz, Matthew H. ;
Rashid, Asif ;
Varadhachary, Gauri R. ;
Wolff, Robert A. ;
Wang, Hua ;
Lee, Jeffrey E. ;
Pisters, Peter W. T. ;
Vauthey, Jean-Nicolas ;
Crane, Christopher ;
Gomez, Henry F. ;
Abbruzzese, James L. ;
Fleming, Jason B. ;
Wang, Huamin .
CANCER, 2012, 118 (12) :3182-3190
[5]   A Pilot Study of Diffusion-Weighted MRI in Patients Undergoing Neoadjuvant Chemoradiation for Pancreatic Cancer [J].
Cuneo, Kyle C. ;
Chenevert, Thomas L. ;
Ben-Josef, Edgar ;
Feng, Mary U. ;
Greenson, Joel K. ;
Hussain, Hero K. ;
Simeone, Diane M. ;
Schipper, Matthew J. ;
Anderson, Michelle A. ;
Zalupski, Mark M. ;
Al-Hawary, Mahmoud ;
Galban, Craig J. ;
Rehemtulla, Alnawaz ;
Feng, Felix Y. ;
Lawrence, Theodore S. ;
Ross, Brian D. .
Translational Oncology, 2014, 7 (05) :644-649
[6]  
EVANS DB, 1992, ARCH SURG-CHICAGO, V127, P1335
[7]   Value of apparent diffusion coefficient (ADC) in assessing radiotherapy and chemotherapy success in cervical cancer [J].
Fu, Zhan-Zhao ;
Peng, Yong ;
Cao, Li-Yan ;
Chen, Yan-Sheng ;
Li, Kun ;
Fu, Bao-Hong .
MAGNETIC RESONANCE IMAGING, 2015, 33 (05) :516-524
[8]   Survival in Locally Advanced Pancreatic Cancer After Neoadjuvant Therapy and Surgical Resection [J].
Gemenetzis, Georgios ;
Groot, Vincent P. ;
Blair, Alex B. ;
Laheru, Daniel A. ;
Zheng, Lei ;
Narang, Amol K. ;
Fishman, Elliot K. ;
Hruban, Ralph H. ;
Yu, Jun ;
Burkhart, Richard A. ;
Cameron, John L. ;
Weiss, Matthew J. ;
Wolfgang, Christopher L. ;
He, Jin .
ANNALS OF SURGERY, 2019, 270 (02) :340-347
[9]   Neoadjuvant FOLFIRINOX in Patients With Borderline Resectable Pancreatic Cancer: A Systematic Review and Patient-Level Meta-Analysis [J].
Janssen, Quisette P. ;
Buettner, Stefan ;
Suker, Mustafa ;
Beumer, Berend R. ;
Addeo, Pietro ;
Bachellier, Philippe ;
Bahary, Nathan ;
Bekaii-Saab, Tanios ;
Bali, Maria A. ;
Besselink, Marc G. ;
Boone, Brian A. ;
Chau, Ian ;
Clarke, Stephen ;
Dillhoff, Mary ;
El-Rayes, Bassel F. ;
Frakes, Jessica M. ;
Grose, Derek ;
Hosein, Peter J. ;
Jamieson, Nigel B. ;
Javed, Ammar A. ;
Khan, Khurum ;
Kim, Kyu-Pyo ;
Kim, Song Cheol ;
Kim, Sunhee S. ;
Ko, Andrew H. ;
Lacy, Jill ;
Margonis, Georgios A. ;
McCarter, Martin D. ;
McKay, Colin J. ;
Mellon, Eric A. ;
Moorcraft, Sing Yu ;
Okada, Ken-Ichi ;
Paniccia, Alessandro ;
Parikh, Parag J. ;
Peters, Niek A. ;
Rabl, Hans ;
Samra, Jaswinder ;
Tinchon, Christoph ;
van Tienhoven, Geertjan ;
van Veldhuisen, Eran ;
Wang-Gillam, Andrea ;
Weiss, Matthew J. ;
Wilmink, Johanna W. ;
Yamaue, Hiroki ;
Homs, Marjolein Y. V. ;
van Eijck, Casper H. J. ;
Katz, Matthew H. G. ;
Koerkamp, Bas Groot .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2019, 111 (08) :782-794
[10]   Apparent Diffusion Coefficient in Estrogen Receptor-Positive Invasive Ductal Breast Carcinoma: Correlations with Tumor-Stroma Ratio [J].
Ko, Eun Sook ;
Han, Boo-Kyung ;
Kim, Rock Bum ;
Cho, Eun Yoon ;
Ahn, Soomin ;
Nam, Seok Jin ;
Ko, Eun Young ;
Shin, Jung Hee ;
Hahn, Soo Yeon .
RADIOLOGY, 2014, 271 (01) :30-37